A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations	Adnexal Diseases, Cancer of the Uterine Cervix, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, breast cancer, breast carcinoma, breast disorder, breast neoplasm, cervical carcinoma, cervix disorder, endocrine system disorder, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian carcinoma, ovarian disorder, prostate cancer, prostate carcinoma, prostate disorder, skin disorder, triple-negative breast carcinoma, uterine disorder	Active, not recruiting	Phase 1	2026-08-07		NCT07038369

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Atavistik Bio, Inc	2

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Centre Leon Berard	Lyon	France	70
Florida Cancer Specialists & Research Institute - Lake Mary	Lake Mary	United States	1
Massachusetts General Hospital	Boston	United States	1015
MD Anderson Cancer Center	Houston	United States	589
National Cancer Centre Singapore	Singapore	Singapore	61
START Madrid - CIOCC	Madrid	Spain	2
Usc Norris Comprehensive Cancer Center	Los Angeles	United States	67
Washington University	St Louis	United States	182